Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

USE OF NEUTRALIZING ANTI-TFG-BETA ANTIBODIES TO MAINTAIN THE SURVIVAL AND DIFFERENTIATION STATE OF HEMATOPOIETIC STEM CELLS (HSC) EX VIVO

  • Read more about USE OF NEUTRALIZING ANTI-TFG-BETA ANTIBODIES TO MAINTAIN THE SURVIVAL AND DIFFERENTIATION STATE OF HEMATOPOIETIC STEM CELLS (HSC) EX VIVO
US Application 61/117,217
Filed on 1999-01-25

Prediction Method for T Cell Epitopes Based on Quantitative Properties of MHC Binding Peptides

  • Read more about Prediction Method for T Cell Epitopes Based on Quantitative Properties of MHC Binding Peptides
US Application 60/416,034
Filed on 2002-10-03

Inhibition of Mitogen-Activated Protein Kinase (MAPK) Pathway As Selective Therapeutic Strategy Against Melanomas

  • Read more about Inhibition of Mitogen-Activated Protein Kinase (MAPK) Pathway As Selective Therapeutic Strategy Against Melanomas
US Application 60/285,690
Filed on 2001-04-24

Methods And Compositions For The Diagnosis And Treatment of Cancer, Including Those Involving the Notch Pathway

  • Read more about Methods And Compositions For The Diagnosis And Treatment of Cancer, Including Those Involving the Notch Pathway
US Application 60/302,788
Filed on 2001-07-03

Macromolecular Imaging Agents For Liver Imaging

  • Read more about Macromolecular Imaging Agents For Liver Imaging
US Application 60/300,882
Filed on 2001-06-25

Novel Metastasis Suppressor Gene on Human Chromosome 8 And Its Use in The Diagnosis, Prognosis and Treatment of Cancer

  • Read more about Novel Metastasis Suppressor Gene on Human Chromosome 8 And Its Use in The Diagnosis, Prognosis and Treatment of Cancer
US Application 60/345,109
Filed on 2001-12-21

New Adenovirus Type 7 Vectors

  • Read more about New Adenovirus Type 7 Vectors
US Application 60/316,361
Filed on 2001-08-30

MRP8, A Member of The ABC Transporter Superfamily Highly Expressed in Breast Cancer, And Uses Thereof

  • Read more about MRP8, A Member of The ABC Transporter Superfamily Highly Expressed in Breast Cancer, And Uses Thereof
US Application 60/305,251
Filed on 2001-07-12

PATE, A Gene Expressed in Prostate Cancer, Prostate And Testis, And Uses Thereof

  • Read more about PATE, A Gene Expressed in Prostate Cancer, Prostate And Testis, And Uses Thereof
US Application 60/298,614
Filed on 2001-06-15

Soybean Leachate: Plant Inhibitor And Potential Cancer therapeutic

  • Read more about Soybean Leachate: Plant Inhibitor And Potential Cancer therapeutic
US Application 60/288,309
Filed on 2001-05-02

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 187
  • Page 188
  • Page 189
  • Page 190
  • Page 191
  • Page 192
  • Page 193
  • Page 194
  • Page 195
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health